Iontophoretic Delivery of Acyclovir: Intradermal Drug Monitoring Using Microdialysis and Quantification by Skin Extraction

References

1. 1.↵
   1. Volpato N. M.,
   2. Nicoli S.,
   3. Laureri C.,
   4. Colombo P.,
   5. Santi P.

   In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J. Controlled Release 1998, 50 (1–3),291–296.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Shukla C.,
   2. Friden P.,
   3. Juluru R.,
   4. Stagni G.

   In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations. J. Pharm. Sci. 2009, 98 (3),917–925.

   OpenUrlPubMed
3. 3.↵
   1. Stagni G.,
   2. Ali M. E.,
   3. Weng D.

   Pharmacokinetics of acyclovir in rabbit skin after i.v.-bolus, ointment, and iontophoretic administrations. Int. J. Pharm. 2004, 274 (1–2),201–211.

   OpenUrlPubMed
4. 4.↵
   1. O'Brien J. J.,
   2. Campoli-Richards D. M.

   Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989, 37 (3),233–309.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Parry G. E.,
   2. Dunn P.,
   3. Shah V. P.,
   4. Pershing L. K.

   Acyclovir bioavailability in human skin. J. Invest. Dermatol. 1992, 98 (6),856–863.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Volpato N. M.,
   2. Santi P.,
   3. Colombo P.

   Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis. Pharm. Res. 1995, 12 (11),1623–1627.

   OpenUrlPubMed
7. 7.↵
   1. Aungst B. J.,
   2. Rogers N. J.,
   3. Shefter E.

   Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986, 33 (1–3),225–234.

   OpenUrlCrossRef
8. 8.↵
   1. Loftsson T.,
   2. Somogyi G.,
   3. Bodor N.

   Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro. Acta Pharm. Nord 1989, 1 (5),279–286.

   OpenUrlPubMed
9. 9.↵
   1. Ranade V. V.

   Drug delivery systems. 6. Transdermal drug delivery. J. Clin. Pharmacol. 1991, 31 (5),401–418.

   OpenUrlPubMed
10. 10.↵
    1. Santus G. C.,
    2. Baker R. W.

    Transdermal enhancer patent literature. J. Controlled Release 1993, 25 (1–2),1–20.

    OpenUrl
11. 11.↵
    1. Lashmar U. T.,
    2. Manger J.

    Investigation of the potential for iontophoresis facilitated transdermal delivery of acyclovir. Int. J. Pharm. 1994, 111 (1),73–82.

    OpenUrl
12. 12.↵
    1. Padula C.,
    2. Sartori F.,
    3. Marra F.,
    4. Santi P.

    The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin. Pharm. Res. 2005, 22 (9),1519–1524.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Wearley L.,
    2. Chien Y.W.

    Enhancement of the in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer. Pharm. Res. 1990, 7 (1),34–40.

    OpenUrlPubMed
14. 14.↵
    1. Gay C. L.,
    2. Green P. G.,
    3. Guy R. H.,
    4. Francoeur M. L.

    Iontophoretic delivery of piroxicam across the skin in vitro. J. Controlled Release 1992, 22 (1),57–67.

    OpenUrl
15. 15.↵
    1. Abla N.,
    2. Naik A.,
    3. Guy R. H.,
    4. Kalia Y. N.

    Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. Pharm. Res. 2006, 23 (8),1842–1849.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Singh P.,
    2. Maibach H. I.

    Iontophoresis: an alternative to the use of carriers in cutaneous drug delivery. Adv. Drug. Deliv. Rev. 1996, 18 (3),379–394.

    OpenUrl
17. 17.↵
    1. Banga A. K.

    Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies; CRC Press: Boca Raton, FL, 2011.
18. 18.↵
    1. Guy R. H.,
    2. Kalia Y. N.,
    3. Delgado-Charro M. B.,
    4. Merino V.,
    5. Lopez A.,
    6. Marro D.

    Iontophoresis: electrorepulsion and electroosmosis. J. Controlled Release 2000, 64 (1–3),129–132.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Stagni G.,
    2. O'Donnell D.,
    3. Liu Y. J.,
    4. Kellogg D. L.,
    5. Morgan T.,
    6. Shepherd A. M.

    Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis. J. Controlled Release 2000, 63 (3),331–339.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Krogstad A. L.,
    2. Jansson P. A.,
    3. Gisslen P.,
    4. Lonnroth P.

    Microdialysis methodology for the measurement of dermal interstitial fluid in humans. Br. J. Dermatol. 1996, 134 (6),1005–1012.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Benfeldt E.

    In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects. Acta Derm. Venereol. Suppl. (Stockholm) 1999, 206, 1–59.

    OpenUrl
22. 22.↵
    1. Borg N.,
    2. Gotharson E.,
    3. Benfeldt E.,
    4. Groth L.,
    5. Stahle L.

    Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm. Venereol. 1999, 79 (4),274–277.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Groth L.

    Cutaneous microdialysis. A new technique for the assessment of skin penetration. Curr. Probl. Dermatol. 1998, 26, 90–98.

    OpenUrlPubMed
24. 24.↵
    1. Herkenne C.,
    2. Alberti I.,
    3. Naik A.,
    4. Kalia Y. N.,
    5. Mathy F. X.,
    6. Preat V.,
    7. Guy R. H.

    In vivo methods for the assessment of topical drug bioavailability. Pharm. Res. 2008, 25 (1),87–103.

    OpenUrlPubMed
25. 25.↵
    1. Farfal S.,
    2. Klimowicz A.,
    3. Bielecka-Grzela S.

    Acyclovir concentrations in the skin of humans after a single oral dose assessed by in vivo cutaneous microdialysis. Skin. Res. Technol. 2006, 12 (4),228–234.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Morgan C. J.,
    2. Renwick A. G.,
    3. Friedmann P. S.

    The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br. J. Dermatol. 2003, 148 (3),434–443.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Klimowicz A.,
    2. Farfal S.,
    3. Bielecka-Grzela S.

    Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid. J. Clin. Pharm. Ther. 2007, 32 (2),143–148.

    OpenUrlPubMed
28. 28.↵
    1. Godin B.,
    2. Touitou E.

    Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv. Drug Deliv. Rev. 2007, 59 (11),1152–1161.

    OpenUrlPubMed
29. 29.↵
    1. Bronaugh R. L.,
    2. Stewart R. F.,
    3. Congdon E. R.

    Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol. 1982, 62 (3),481–488.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Kikwai L.,
    2. Babu R. J.,
    3. Prado R.,
    4. Kolot A.,
    5. Armstrong C. A.,
    6. Ansel J. C.,
    7. Singh M.

    In vitro and in vivo evaluation of topical formulations of Spantide II. AAPS PharmSciTech 2005, 6 (4),E565–E572.

    OpenUrlPubMed
31. 31.↵
    1. Lauer A. C.,
    2. Elder J. T.,
    3. Weiner N. D.

    Evaluation of the hairless rat as a model for in vivo percutaneous absorption. J. Pharm. Sci. 1997, 86 (1),13–18.

    OpenUrlPubMed
32. 32.↵
    1. Morimoto Y.,
    2. Hatanaka T.,
    3. Sugibayashi K.,
    4. Omiya H.

    Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J. Pharm. Pharmacol. 1992, 44 (8),634–639.

    OpenUrlPubMedWeb of Science
33. 33.↵
    1. Sachdeva V.,
    2. Siddoju S.,
    3. Yu Y. Y.,
    4. Kim H. D.,
    5. Friden P. M.,
    6. Banga A. K.

    Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. Int. J. Pharm. 2010, 388 (1–2),24–31.

    OpenUrlPubMed
34. 34.↵
    1. Sachdeva V.,
    2. Kim H. D.,
    3. Friden P. M.,
    4. Banga A. K.

    Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride. Int. J. Pharm. 2010, 393 (1–2),112–118.

    OpenUrlPubMed
35. 35.↵
    1. Vemulapalli V.,
    2. Yang Y.,
    3. Friden P. M.,
    4. Banga A. K.

    Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J. Pharm. Pharmacol. 2008, 60 (1),27–33.

    OpenUrlPubMedWeb of Science
36. 36.↵
    1. Volpato N. M.,
    2. Santi P.,
    3. Laureri C.,
    4. Colombo P.

    Assay of acyclovir in human skin layers by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 1997, 16 (3),515–520.

    OpenUrlPubMed
37. 37.↵
    1. Kristl A.,
    2. Tukker J. J.

    Negative correlation of n-octanol/water partition coefficient and transport of some guanine derivatives through rat jejunum in vitro. Pharm. Res. 1998, 15 (3),499–501.

    OpenUrlPubMed
38. 38.↵
    1. Kristl A.,
    2. Mrhar A.,
    3. Kozjek F.

    The ionisation properties of acyclovir and deoxyacyclovir. Int. J. Pharm. 1993, 99 (1),79–82.

    OpenUrl
39. 39.↵
    1. Merino V.,
    2. López A.,
    3. Kalia Y. N.,
    4. Guy R. H.

    Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 1999, 16 (5),758–761.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Stagni G.,
    2. O'Donnell D.,
    3. Liu Y. J.,
    4. Kellogg D.L. Jr..,
    5. Shepherd A. M.

    Iontophoretic current and intradermal microdialysis recovery in humans. J. Pharmacol. Toxicol. Methods 1999, 41 (1),49–54.

    OpenUrlCrossRefPubMed